PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3499, doi. 10.1038/onc.2009.191
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 39
Results: 7
1
2
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3487, doi. 10.1038/onc.2009.205
- By:
- Publication type:
- Article
3
5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3429, doi. 10.1038/onc.2009.207
- By:
- Publication type:
- Article
4
Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3468, doi. 10.1038/onc.2009.208
- By:
- Publication type:
- Article
5
Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3477, doi. 10.1038/onc.2009.209
- By:
- Publication type:
- Article
6
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3442, doi. 10.1038/onc.2009.212
- By:
- Publication type:
- Article
7
Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence.
- Published in:
- Oncogene, 2009, v. 28, n. 39, p. 3456, doi. 10.1038/onc.2009.222
- By:
- Publication type:
- Article